Literature DB >> 33136746

Brief Report: Cystatin C-Based Estimation of Glomerular Filtration Rate and Association With Atherosclerosis Imaging Markers in People Living With HIV.

Mitchell McClean1, Petra Buzkova2, Matthew Budoff3, Michelle Estrella4, Matthew Freiberg5, Howard N Hodis6, Frank Palella7, Cecilia Shikuma8, Wendy S Post9, Samir Gupta1.   

Abstract

INTRODUCTION: Reduced estimated glomerular filtration rate (eGFR) is associated with increased risk of cardiovascular disease among people living with HIV (PLWH). It is unclear whether eGFR equations incorporating cystatin C (CysC) measurements are more predictive of preclinical cardiovascular disease than those using only creatinine (Cr).
OBJECTIVES: The study aimed to determine which of the 3 Chronic Kidney Disease Epidemiology (CKD-EPI) eGFR equations is most associated with carotid intima media thickness (CIMT) and coronary artery calcium (CAC) score.
METHODS: This cross-sectional analysis of pooled data from 3 large cohorts compared the associations between the 3 CKD-EPI eGFR equations (Cr, CysC, and Cr-CysC) with CIMT and CAC score using multivariable regression analysis. eGFR and CIMT were analyzed as continuous variables. CAC scores were analyzed as a binary variable (detectable calcification versus nondetectable) and as a log10 Agatston score in those with detectable CAC.
RESULTS: Thousand four hundred eighty-seven participants were included, and of these 910 (562 HIV+ and 348 HIV-) had CIMT measurements and 366 (296 HIV+ and 70 HIV-) had CAC measurements available. In HIV- participants, GFR estimated by any CKD-EPI equation did not significantly correlate with CIMT or CAC scores. When PLWH were analyzed separately including HIV-specific factors, only GFR estimated using Cr-Cys C correlated with CIMT [β= -0.90, 95% CI: (-1.67 to -0.13) μm; P = 0.023]. Similarly, eGFR correlated with Agatston scores only when using cystatin C-based eGFR [β= -8.63, 95% CI: (-16.49 to -0.77) HU; P = 0.034]. Associations between other eGFR formulas and CAC did not reach statistical significance.
CONCLUSIONS: In PLWH, preclinical atherosclerosis may be more closely correlated with eGFR using formulae that incorporate CysC measurements than Cr alone.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33136746      PMCID: PMC7879707          DOI: 10.1097/QAI.0000000000002467

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  26 in total

1.  Comparison of cystatin C and creatinine to determine the incidence of composite adverse outcomes in HIV-infected individuals.

Authors:  Naoki Yanagisawa; Shugo Sasaki; Akihiko Suganuma; Akifumi Imamura; Atsushi Ajisawa; Minoru Ando
Journal:  J Infect Chemother       Date:  2014-11-20       Impact factor: 2.211

2.  Progression of coronary artery calcium predicts all-cause mortality.

Authors:  Matthew J Budoff; John E Hokanson; Khurram Nasir; Leslee J Shaw; Gregory L Kinney; David Chow; Daniel Demoss; Vivek Nuguri; Vahid Nabavi; Raghu Ratakonda; Daniel S Berman; Paolo Raggi
Journal:  JACC Cardiovasc Imaging       Date:  2010-12

3.  Markers of atherosclerosis and inflammation and mortality in patients with HIV infection.

Authors:  Alexandra Mangili; Joseph F Polak; Lien A Quach; Jul Gerrior; Christine A Wanke
Journal:  Atherosclerosis       Date:  2010-11-17       Impact factor: 5.162

4.  Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Matthew J Budoff; Daniel J Rader; Muredach P Reilly; Emile R Mohler; Jim Lash; Wei Yang; Leigh Rosen; Melanie Glenn; Valerie Teal; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2011-07-23       Impact factor: 8.860

5.  Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.

Authors:  Michelle C Odden; Rebecca Scherzer; Peter Bacchetti; Lynda Anne Szczech; Stephen Sidney; Carl Grunfeld; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2007-11-12

6.  Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study.

Authors:  Carl Grunfeld; Joseph A C Delaney; Christine Wanke; Judith S Currier; Rebecca Scherzer; Mary L Biggs; Phyllis C Tien; Michael G Shlipak; Stephen Sidney; Joseph F Polak; Daniel O'Leary; Peter Bacchetti; Richard A Kronmal
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

7.  Association of biomarkers with atherosclerosis and risk for coronary artery disease in patients with HIV.

Authors:  Maria da Conceição Brandão de Arruda Falcão; Josefina Cláudia Zírpoli; Valéria Maria de Albuquerque; Brivaldo Markman Filho; Nelson Antônio Moura de Araújo; Creso Abreu Falcão; Demócrito de Barros Miranda-Filho; Ricardo Alencar de Arraes Ximenes; Maria de Fátima Militão de Albuquerque; Heloísa Ramos Lacerda
Journal:  Arq Bras Cardiol       Date:  2012-10-18       Impact factor: 2.000

8.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

9.  Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons.

Authors:  Andy I Choi; Yongmei Li; Steven G Deeks; Carl Grunfeld; Paul A Volberding; Michael G Shlipak
Journal:  Circulation       Date:  2010-01-25       Impact factor: 29.690

10.  Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals.

Authors:  G M Lucas; A Cozzi-Lepri; C M Wyatt; F A Post; A M Bormann; N F Crum-Cianflone; M J Ross
Journal:  HIV Med       Date:  2013-09-11       Impact factor: 3.180

View more
  2 in total

1.  Correlation of Serum CysC, IMA, and LP-PLA2 Levels With Type 2 Diabetes Mellitus Patients With Lower Extremity Atherosclerotic Occlusive Disease.

Authors:  Fen Feng; Yong Chen; Gang Wang; Ping Huang; Qiaolin Zhu; Bin Zhou
Journal:  Front Surg       Date:  2022-03-09

2.  Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study.

Authors:  Malcolm West; Adrienne Kirby; Ralph A Stewart; Stefan Blankenberg; David Sullivan; Harvey D White; David Hunt; Ian Marschner; Edward Janus; Leonard Kritharides; Gerald F Watts; John Simes; Andrew M Tonkin
Journal:  J Am Heart Assoc       Date:  2022-02-18       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.